Search this site

Explore brainstem neurosurgery with The Neurosurgical Case Room (TNCR), covering surgical anatomy, safe entry zones, brainstem lesions and principles of operative management. Brainstem | Applied Clinical Anatomy & Surgical Approaches Far-lateral Transcondylar Approach The farlateral transcondylar approach is one of the most powerful skull base corridors for lesions at the foramen magnum, ventral brainstem, and lower clivus. In this video, we break it down step by step in a clear, structured, and exam-focused manner. Medulla Oblongata | Rule of 4, Tracts, & Nuclei In this detailed masterclass, we break down the complex anatomy of the brainstem with special focus on the medulla oblongata — integrating topographic anatomy, internal structure, ascending & descending tracts, nuclei, and surgical relevance. Medulla Oblongata | Surgical Anatomy, Nuclei, and Safe Zones The discussion integrates surface landmarks, internal nuclei, long tracts, and clinically relevant safe entry zones, translating complex brainstem anatomy into real-world surgical decision-making. Surgical Approaches to Medulla The discussion covers midline suboccipital exposure, cerebellomedullary fissure dissection, opening of the tela choroidea and inferior medullary velum, and the principles of approaching intrinsic medullary and fourth ventricular lesions while preserving critical neurovascular structures. Telovelar & Far Lateral Approach The video integrates suboccipital craniectomy, cerebellomedullary fissure dissection, and anatomical corridors to safely access intrinsic medullary and fourth ventricular lesions. Emphasis is placed on surgical anatomy, approach selection, and operative strategy for brainstem pathology. Surgical Anatomy of the Pons & Safe Surgical Zones The discussion focuses on the key anatomical landmarks of the basilar sulcus, middle cerebellar peduncle, facial colliculus, and cranial nerve exit zones, which guide safe operative corridors to intrinsic pontine lesions. Surgical Anatomy of Midbrain & Safe Surgical Zones The video explains the principles behind safe entry zones of the midbrain, their relationship to critical neural pathways, and how these zones guide surgical approaches for brainstem tumors, cavernous malformations, and intrinsic midbrain lesions.

Review congenital neurosurgery with The Neurosurgical Case Room (TNCR), covering hydrocephalus, neural tube defects, craniosynostosis, Chiari malformations and other congenital conditions. CONGENITAL Aqueductal Stenosis → Klippel Feil Syndrome → Arachnoid Cyst → Lipomyelomeningocele → Basilar Invagination → Occult Spinal Dysraphisms & Filar Pathologies → Chiari Malformations → Myelomeningocele → Craniosynostosis → Myeloschisis → CVJ Anomalies → Os Odontoideum → Dandy Walker Malformation → Spinal Dysraphism → Encephalocele → Split Cord Malformation → Growing Skull Fracture → Tethered Cord Syndrome → Hydrocephalus → Torticollis →

Explore torticollis with The Neurosurgical Case Room (TNCR), including causes, clinical presentation, evaluation, differential diagnosis and principles of neurosurgical management. Torticollis Q. What is torticollis? Torticollis is an abnormal, involuntary positioning of the head and neck caused by unilateral contraction or dysfunction of the cervical muscles, most commonly the sternocleidomastoid. It results in the head tilting to one side and rotating to the opposite side. It may be congenital, acquired, or secondary to neuromuscular, ocular, skeletal, or dystonic causes. Q. What are the types of torticollis? Torticollis is broadly divided into congenital muscular torticollis and acquired torticollis. Congenital muscular torticollis usually results from fibrosis or shortening of the sternocleidomastoid, often associated with birth trauma, intrauterine malposition, or associated musculoskeletal anomalies. Acquired torticollis may arise from atlantoaxial subluxation, posterior fossa pathology, Chiari malformation, syringomyelia, spinal tumors, cervical infections, dystonia, ocular imbalance, drug-induced dystonia, or inflammatory conditions of the cervical musculature. Q. What is the pathophysiology of congenital muscular torticollis? Congenital muscular torticollis results from fibrosis or shortening of the sternocleidomastoid because the injured muscle undergoes scarring after perinatal trauma or intrauterine compression, and the resulting contracture pulls the head into ipsilateral tilt with contralateral rotation. It may also be associated with intrauterine malposition because constant asymmetric pressure on the fetal neck leads to muscle ischemia and subsequent fibrosis. Musculoskeletal anomalies may contribute by altering neck alignment and creating compensatory muscle imbalance that fixes the head posture. Q. How is congenital muscular torticollis classified, and why is this important? Congenital muscular torticollis is classified into three subtypes: the sternocleidomastoid mass type, the muscular torticollis without mass type, and the postural torticollis type. The sternocleidomastoid mass type presents with a firm, fusiform enlargement of the muscle in infancy and represents the most fibrotic subtype, often requiring longer physiotherapy and sometimes earlier surgical intervention. The muscular torticollis without mass type has no discrete swelling but still demonstrates true muscle tightness, usually responding well to therapy. Postural torticollis is the mildest subtype, characterized by positional preference without true fibrosis, and resolves quickly with repositioning and stretching. Q. What causes acquired torticollis? Acquired torticollis arises from multiple structural or functional disturbances. Atlantoaxial subluxation causes torticollis because rotational or lateral displacement of C1 on C2 forces the head into a fixed tilted posture to maintain comfort and avoid pain from ligamentous strain. Posterior fossa pathology, including Chiari malformation, causes abnormal head posture because tonsillar descent and cervicomedullary crowding preferentially increase tone or spasm in one group of cervical muscles, leading to asymmetric neck positioning. Syringomyelia produces torticollis when the expanding syrinx distorts spinal cord pathways regulating neck muscle tone, causing imbalance in motor output. Cervical or spinal tumors cause unilateral muscle spasm or nerve root irritation, producing protective head tilt to reduce discomfort. Cervical infections, such as in the paraspinal soft tissues or the retropharyngeal space, lead to torticollis because inflammation and pain trigger reflex muscle spasm that locks the neck in the least painful position. Dystonia causes torticollis due to basal ganglia dysfunction that generates involuntary, asymmetric contraction of cervical muscles. Drug-induced dystonia, particularly from dopamine-blocking agents, causes sustained involuntary contraction of neck muscles due to acute extrapyramidal dysfunction, leading to abnormal head positioning. Ocular imbalance results in torticollis because the patient positions the head to optimize visual alignment and reduce diplopia, and the habitual compensatory posture becomes fixed over time. Finally, inflammatory conditions of the cervical musculature cause focal pain and reflex spasm, and the resulting contracture forces the neck into a position that minimizes pain, producing torticollis. Q. What is ocular torticollis, and why is it significant? Ocular torticollis refers to abnormal head posture adopted to compensate for impaired ocular alignment, most commonly superior oblique palsy, horizontal muscle imbalance, or vertical strabismus. The child tilts or rotates the head to maintain binocular vision and reduce diplopia, and because this compensatory posture becomes habitual, it mimics cervical torticollis. The sternocleidomastoid is often normal on palpation and full passive range of motion is preserved. Recognizing ocular torticollis is critical because neck surgery or aggressive physiotherapy would not correct the underlying issue, and the head tilt resolves only when the ocular misalignment is managed by an ophthalmologist. Missing this diagnosis may expose the child to unnecessary orthopaedic or neurosurgical intervention. Q. What is Grisel’s syndrome, and why is it an important cause of torticollis? Grisel’s syndrome is a non-traumatic atlantoaxial rotatory subluxation resulting from inflammatory laxity of the transverse and alar ligaments following upper airway infection or ENT surgery, most commonly adenotonsillectomy. The inflammatory process spreads to the atlantoaxial joint through the pharyngovertebral venous plexus, leading to ligamentous weakening and subsequent subluxation. Children present with acute painful torticollis, limited rotation, and resistance to passive correction. It is an important cause because early recognition allows treatment with anti-inflammatory therapy, immobilization, and sometimes traction, while delayed diagnosis may lead to fixed deformity requiring surgical stabilization. Q. What clinical features do you expect in torticollis? Patients typically present with a fixed head tilt toward the affected side with rotation away from it. Congenital cases present early in infancy with palpable tightness or mass in the sternocleidomastoid. Long-standing cases may show facial asymmetry, plagiocephaly, and restricted neck range of motion. Acquired cases may present acutely or insidiously with neck pain, neurological deficits if due to Chiari or syrinx, restricted ocular movements in ocular torticollis, and dystonic twisting movements in spasmodic forms. Q. What associated anomalies may accompany congenital torticollis? Common associations include developmental dysplasia of the hip, metatarsus adductus, clavicular fractures, brachial plexus birth injuries, and craniofacial asymmetry. Cervical spine anomalies may coexist, though less frequently. Q. What investigations will you perform for a case of torticollis? Investigation of torticollis depends on determining what the suspected cause is, and therefore a structured multilevel approach is required. MRI of the brain and craniovertebral junction is the most important investigation. CT scan of the cervical spine and craniovertebral junction is essential for evaluating bony abnormalities. EMG of the neck muscles helps differentiate dystonic torticollis from extrapyramidal or neuromuscular causes because abnormal grouped discharges support dystonia, whereas normal EMG favors structural or ocular etiologies. In congenital muscular torticollis, ultrasound of the sternocleidomastoid is commonly added because it identifies fibrosis, muscle thickness, and mass-type lesions, helping differentiate the sternocleidomastoid mass subtype from postural preference. In cases suspicious for atlantoaxial instability, dynamic cervical X-rays in flexion and extension help evaluate instability, although CT remains more definitive for C1–C2 alignment. When ocular torticollis is suspected, a full ophthalmologic evaluation including ocular motility testing and cover–uncover tests is necessary to identify superior oblique palsy or strabismus. In suspected infections, inflammatory markers such as CBC, ESR, and CRP can also be done. Q. How will you distinguish spasmodic torticollis from tardive dystonia? Spasmodic torticollis is a primary cervical dystonia arising from abnormal basal ganglia output, producing involuntary twisting, pulling, or jerking of the neck, often with a sensory trick that temporarily improves posture. In contrast, tardive dystonia results from chronic exposure to dopamine-blocking medications such as antipsychotics or antiemetics, usually developing in adolescents or young adults. Tardive dystonia tends to be more generalized, more painful, and more persistent, and may coexist with other tardive syndromes. The distinction is important because spasmodic torticollis often responds well to botulinum toxin and deep brain stimulation of the globus pallidus internus, while tardive dystonia requires withdrawal of the offending drug, anticholinergic therapy, benzodiazepines, and, in severe cases, deep brain stimulation tailored specifically for medication-induced dystonia. Misidentification of tardive dystonia leads to incomplete treatment and continuation of the causative agent. Q. What is the natural history of untreated congenital muscular torticollis? Untreated congenital muscular torticollis leads to progressive craniofacial asymmetry because persistent tilt alters skull molding, producing plagiocephaly, orbital asymmetry, mandibular deviation, and ear displacement. Over time, the cervical spine compensates by developing cervicothoracic scoliosis and lateral curvature. The sternocleidomastoid fibrosis becomes more rigid, reducing the chance of recovery with physiotherapy and often necessitating surgical release. The visual system may also adapt abnormally, producing ocular tracking asymmetry. Long-standing deformity can persist into adulthood, causing aesthetic concerns, neck pain, restricted rotation, and compensatory malalignment of the shoulders and upper spine. Early intervention is essential to prevent these long-term musculoskeletal and facial consequences. Q. How will you manage congenital muscular torticollis? Initial management is conservative and consists of physiotherapy aimed at gentle passive stretching of the sternocleidomastoid, positioning therapy, and caregiver-guided exercises. Most cases resolve with structured therapy over months. If the child presents late, has severe deformity, or fails conservative treatment beyond one year of age, surgical lengthening or release of the sternocleidomastoid is indicated. After surgery, physiotherapy and splinting ensure symmetrical neck posture and prevent recurrence. Q. When is surgery indicated in congenital muscular torticollis? Surgery is indicated when limitation of passive rotation or lateral bending persists beyond twelve months of age despite consistent physiotherapy, when a firm fibrotic band remains on ultrasound, or when the deformity is severe enough to cause craniofacial asymmetry that is unlikely to reverse spontaneously. Failure of conservative management, late presentation after infancy, or a residual tilt persisting after an adequate trial of therapy all justify operative release. The goal is to correct the contracture before the secondary changes in the spine and facial skeleton become fixed. After surgical release, early physiotherapy and proper postoperative positioning are essential to maintain correction. Q. How will you manage acquired torticollis? Management is guided by the underlying cause. Inflammatory or infectious causes respond to anti-inflammatory treatment, antibiotics, and rest. Ocular torticollis requires ophthalmologic correction. Drug-induced dystonia resolves with withdrawal of the offending agent and administration of anticholinergics. Chiari malformation–related torticollis improves after posterior fossa decompression when symptomatic or associated with syringomyelia. Cervical spine anomalies or atlantoaxial rotatory fixation require immobilization, traction, or surgical stabilization depending on severity. Dystonic torticollis may be managed with botulinum toxin injection or neuromodulatory procedures in refractory cases. Q. Describe the role of deep brain stimulation in the management of torticollis. Deep brain stimulation is used in the management of refractory cervical dystonia when medical therapy and repeated botulinum toxin injections fail to provide durable symptom control. DBS of the bilateral globus pallidus internus is effective because high-frequency stimulation suppresses the pathological oscillatory firing patterns responsible for dystonic motor output. By modulating this abnormal pallidal activity, deep brain stimulation reduces the excessive drive to the sternocleidomastoid, splenius, levator scapulae and other cervical muscles, allowing more balanced activation of antagonists and improved head alignment. The selection of patients for deep brain stimulation requires confirmation of true dystonic torticollis rather than spastic, ocular, inflammatory, or structural causes, because deep brain stimulation targets the central motor network and will not correct peripheral or mechanical etiologies. Once implanted, deep brain stimulation gradually improves posture over weeks to months as the central motor circuits remodel in response to continuous stimulation. Patients often experience substantial reduction in pain, improved range of motion, better functional positioning, and a reduction in the severity and frequency of involuntary neck spasms. The benefit is long-lasting, reversible, and adjustable, which makes deep brain stimulation an important option in severe cervical dystonia, particularly in patients with progressive disability or fixed abnormal posturing from years of untreated dystonic drive. Q. What complications may occur following deep brain stimulation for torticollis? Complications may arise from the hardware, the operation, or the stimulation itself. Hardware problems include lead migration, insulation failure, or connector malfunction due to mechanical stress along the cervical–thoracic course. Surgical risks include intracranial hemorrhage along the electrode tract and device-related infection, which may require hardware removal. Stimulation can cause dysarthria, bradykinesia, imbalance, or mood changes when current spreads beyond the globus pallidus internus. Q. What are the denervation procedures used for torticollis? Denervation procedures are reserved for patients with focal dystonic torticollis in whom selective muscle overactivity is well localized and when botulinum toxin or medical therapy fails. The principle is to interrupt the motor innervation of the dystonic muscles so that the involuntary contractions cease, allowing the head to return toward a neutral position under the control of the non-dystonic antagonists. These procedures target the spinal accessory nerve branches supplying the sternocleidomastoid or the posterior primary rami innervating the splenius capitis, semispinalis capitis, or other hyperactive posterior cervical muscles. By sectioning or coagulating only the branches supplying the dystonic portion of the muscle, selective denervation preserves the function of the remaining cervical musculature and prevents global weakness. This is based on the observation that cervical dystonia frequently involves asymmetric overactivation of one or two dominant muscle groups rather than a generalized pattern. Denervation reduces involuntary spasms because it eliminates the peripheral efferent drive, interrupting the final common pathway through which abnormal basal ganglia signals manifest. Over time, the antagonistic muscles regain better control as the abnormal pulling force disappears. Denervation is most successful when the dystonia is focal, the pattern is stable, and electromyographic mapping clearly identifies the hyperactive muscles. Although not as commonly performed, it remains an option for highly selected patients with well-defined dystonic circuitry who are poor candidates for more invasive neuromodulatory procedures. Q. What complications may arise after selective denervation procedures for torticollis? Selective denervation may produce excessive weakness if too many branches are cut, leading to head drop or loss of postural control, while inadequate denervation results in persistent dystonia. Sensory nerve irritation or neuroma formation can generate neuropathic pain. Scar tissue may limit neck mobility, and deep dissection may injure nearby structures such as the internal jugular vein. Long-term recurrence may occur due to collateral nerve sprouting, emphasizing the need for accurate mapping and careful patient selection. Q. What neuromodulatory options exist for torticollis apart from selective sectioning? Dorsal column stimulation: The spinal cord stimulation at the cervical level modulates segmental and supraspinal circuits involved in dystonic posturing; this is less commonly used but may benefit selected patients with refractory dystonia. Botulinum toxin injection represents a chemical neuromodulation method, weakening dystonic muscles by blocking neuromuscular transmission and thereby reducing involuntary contractions; although its effect is temporary, it remains a first-line neuromodulatory therapy. Microvascular decompression of the spinal accessory nerve is indicated in rare torticollis caused by vascular compression at the nerve entry zone, and decompression restores normal nerve firing over time. Stereotactic lesioning procedures targeting areas such as Forel’s H1 field or thalamic nuclei can interrupt abnormal motor network activity in severe refractory cases, although these are now less common due to the preference for adjustable and reversible deep brain stimulation. Q. How will you surgically release the sternocleidomastoid in congenital muscular torticollis? Surgical release of the sternocleidomastoid is performed when congenital muscular torticollis fails to respond to prolonged physiotherapy or when the child presents late with fixed fibrosis and persistent tilt. I will position the patient supine with slight extension and rotate the head to expose the tight sternocleidomastoid. I will make a small transverse incision along a natural skin crease low in the neck, directly over the clavicular and sternal heads of the muscle. I will carefully dissect through the subcutaneous tissue and platysma until the fibrotic sternocleidomastoid is identified. Once exposed, I will isolate the sternal and clavicular heads and then release them from their attachments at the manubrium and clavicle. If the deformity is severe or if mid-muscle contracture is evident, I will extend the release proximally and perform bipolar release by freeing the upper attachment near the mastoid, ensuring that the great auricular nerve and accessory nerve are preserved. After the release, I will gently stretch the neck through its full passive range of motion to confirm that the contracture is corrected and the head can be positioned neutrally. Hemostasis will be secured and the wound closed in layers. Postoperatively, I will begin physiotherapy early to maintain the newly gained range. The child will undergo a structured program of stretching, strengthening of the contralateral sternocleidomastoid, and positioning techniques to prevent recurrence. Nighttime bracing or orthosis may be used initially to maintain correction. Over the following months, muscle balance gradually normalizes, and the facial asymmetry improves as the child grows. Q. What complications may occur after surgical release of the sternocleidomastoid in congenital muscular torticollis? Complications include injury to the spinal accessory nerve resulting in trapezius weakness or shoulder droop, and injury to the great auricular nerve causing sensory loss over the auricle and jaw angle. Inadequate release leads to persistent tilt, while over-release causes cosmetic deformity or imbalance between neck muscles. Hematoma or infection may limit postoperative motion and promote fibrosis. Recurrence is the most important long-term risk if physiotherapy is not maintained, making postoperative stretching and bracing essential. Q. What is the prognosis? Congenital muscular torticollis treated early has an excellent prognosis with near-complete correction. Late treatment may leave residual facial asymmetry. Acquired torticollis prognosis depends on etiology: inflammatory and ocular causes usually resolve completely; dystonic and neurogenic causes may persist chronically; and Chiari-related torticollis often improves significantly following appropriate decompression.

Explore medulloblastomas with The Neurosurgical Case Room (TNCR), including molecular classification, clinical presentation, imaging, surgical management and principles of adjuvant therapy. Medulloblastoma Medulloblastoma | Pathology, Imaging & Clinical Presentation This session on Medulloblastoma covers its clinical presentation, radiologic features, molecular subgroups, and surgical considerations, discussed through real neurosurgical cases. Medulloblastoma vs Ependymoma | Management, Surgical Principles & Key Differences The discussion emphasizes extent of resection, surgical goals, and common intraoperative considerations, along with side-by-side imaging features that help distinguish medulloblastoma from posterior fossa ependymoma. Medulloblastoma | Risk Stratification This session on Medulloblastoma Risk Stratification reviews how clinical, radiologic, surgical, and molecular factors are integrated to categorize patients into prognostic risk groups.

Explore subdural empyema with The Neurosurgical Case Room (TNCR), including clinical presentation, imaging, diagnosis, antimicrobial therapy and principles of surgical management. Subdural Empyema Subdural empyema is a localized collection of pus in the subdural space between the dura and arachnoid, most often arising as a complication of sinus, ear, or cranial infection. It is a neurosurgical emergency due to rapid expansion, cortical compression, and high mortality if untreated. Q. What is the pathogenesis of subdural empyema? Infection spreads by direct extension from nearby sources such as paranasal sinuses, mastoid air cells, or middle ear. Spread occurs through valveless diploic veins, cortical veins, or emissary veins leading into the subdural space. The infection causes pus accumulation, venous thrombophlebitis, cortical necrosis, and local cerebritis. May coexist with cerebral abscess in 20–25% of cases. Q. What are the common etiologies? 1. Frontal or ethmoidal sinusitis: most common 2. Otitis media and mastoiditis 3. Postoperative or post-traumatic causes (compound fractures, contaminated craniotomies) 4. Meningitis (especially pneumococcal in infants) 5. Septic cortical venous thrombosis or bacteremia Q. What are the common causative organisms? Aerobes: Streptococcus milleri, Staphylococcus aureus, Streptococcus pneumoniae. Anaerobes: Bacteroides, Peptostreptococcus, Fusobacterium. Post-surgical / post-traumatic: Staphylococcus aureus, Pseudomonas aeruginosa, Enterobacteriaceae. Immunocompromised hosts: Aspergillus, Candida, Nocardia. Q. What are the common sites of involvement? 70–80% occur over the cerebral convexity. 10–20% are parafalcine (interhemispheric). Posterior fossa involvement is rare and usually secondary to otitis or mastoiditis. Empyema may extend rapidly across the convexity due to the lack of barriers in the subdural space. Q. What are the associated and secondary complications? Cerebral abscess (in 20–25% of cases) Cortical venous thrombosis Localized cerebritis or extension into brain parenchyma Spinal subdural empyema (hematogenous dissemination) Meningitis, seizures, or hydrocephalus Q. How does it differ from epidural abscess and cerebral abscess? Epidural abscess: Between bone and dura; limited by dural attachments. Subdural empyema: Between dura and arachnoid; spreads freely over convexity. Cerebral abscess: Within brain parenchyma; encapsulated. Q. What are the clinical features? Fever and severe headache: Rapidly progressive Focal neurological deficits: Hemiparesis, aphasia, cranial nerve palsies Seizures: Occur in 40–50% acutely; persistent seizures in up to 34% long-term Signs of raised ICP: Papilledema, vomiting, altered sensorium, coma Meningeal signs: Neck stiffness, photophobia. Rapid deterioration within 24–48 hours is characteristic. Q. What are the laboratory findings? Leukocytosis with left shift CRP and ESR elevated in almost all cases Blood cultures positive in 30–40% Lumbar puncture is contraindicated because of high risk of herniation. Q. What are the characteristic imaging features? CT with contrast: Crescentic or lentiform hypodense extra-axial collection over convexity or falx. Enhancing inner margin (arachnoid side) — double arc sign. Associated sinus or mastoid opacification. Mass effect, midline shift, compression of sulci. MRI: T1: Iso- to hypointense extra-axial collection with enhancing inner rim. T2: Hyperintense fluid collection with surrounding cortical edema. DWI: Restricted diffusion (helps differentiate from sterile effusion). MR venography: may reveal cortical venous or sagittal sinus thrombosis. MRI is superior to CT for early detection, interhemispheric spread, or posterior fossa lesions. Q. How will you manage a case of subdural empyema? It is a neurosurgical emergency, immediate antibiotics and surgical drainage are mandatory. 1. Medical management (initial stabilization) Empirical IV antibiotics: Ceftriaxone 2 g IV q12h + Metronidazole 500 mg IV q6h. Add Vancomycin 15 mg/kg IV q8–12h if postoperative or trauma-related. If Pseudomonas suspected: Cefepime 2 g IV q8h or Meropenem 2 g IV q8h. Adjust based on cultures. ICP management: Head elevation, mannitol. Anticonvulsants for all patients. Steroids reserved for massive edema threatening herniation. 2. Surgical management Indications: - Any established subdural collection - Clinical deterioration or focal deficits - Midline shift, mass effect, or radiologic evidence of pus - Failure of conservative therapy Techniques: Emergency craniotomy with evacuation of pus and irrigation of subdural space. Burr-hole drainage only if the patient is moribund or too unstable for craniotomy, but recurrence rate is higher. Repeat exploration for reaccumulation (in 10–20%) Posterior fossa empyema: Suboccipital craniectomy Simultaneous management of primary focus (sinus drainage, mastoidectomy, or ENT repair). Contraindications: None absolute except deep coma with absent brainstem reflexes. 3. Postoperative and adjunctive care Continue IV antibiotics for at least 6 weeks or until MRI shows complete resolution. Serial imaging (MRI preferred) every 3–5 days initially, then weekly. Seizure prophylaxis for 6–12 months. Monitor for cortical venous thrombosis clinically and via MRV if deterioration occurs. Control of primary source (sinus or ear infection) is essential to prevent recurrence. Q. What are the complications? Recurrence or reaccumulation Cortical venous thrombosis Localized cerebritis or progression to brain abscess Spinal subdural empyema Hydrocephalus, seizures, or permanent focal deficits Mortality: 10–20% even with timely treatment Q. What is the prognosis? Mortality 10–20% overall Persistent seizures in 34% of survivors Neurological deficits in up to 50% Prognosis excellent with early surgery and appropriate antibiotic therapy Q. What is the follow-up protocol? MRI at 2 weeks, then monthly till resolution. Continue antibiotics until imaging and CRP normalize. Continue AEDs 6–12 months. Evaluate sinus and mastoid cavities for residual infection. Recalls: Frontal or ethmoidal sinusitis is the most common source. Spread via valveless diploic veins. 70–80% convexity; 10–20% parafalcine. 20–25% associated with cerebral abscess. Cortical venous thrombosis, localized cerebritis, or spinal SDE → known complications. CT crescentic collection with enhancing inner margin is the hallmark. LP is contraindicated. Craniotomy with evacuation is the treatment of choice. Mortality 10–20%, and persistent seizures 34%.

Review tuberculum sellae meningioma with concise neurosurgical notes covering anatomy, clinical features, imaging, surgical approaches, management, and key exam points. Tuberculum Sella Meningioma A tuberculum sellae meningioma is a skull-base tumor originating from the dura of the tuberculum sellae, chiasmatic sulcus, and limbus sphenoidale. It arises in a narrow corridor bounded superiorly by the optic nerves and chiasm, laterally by the supraclinoid internal carotid arteries (ICA), and inferiorly by the diaphragma sellae. Its surgical difficulty stems from its intimate relationship with the ophthalmic arteries, A1 segments, displaced pituitary stalk, and particularly the superior hypophyseal perforators supplying the optic apparatus. Q. How does tumor origin on the tuberculum sellae influence its growth pattern and clinical behavior? Originating beneath the chiasm within the shallow basin of the chiasmatic sulcus, the tumor expands upward, backward, and laterally. This produces characteristic elevation and posterior displacement of the chiasm, along with thinning of the pituitary stalk. Because critical neural structures lie immediately above its point of origin, even small tumors produce early visual deficits long before reaching a large size. Q. What structural and embryologic features predispose these tumors to optic canal invasion? The tuberculum sellae and planum sphenoidale derive from presphenoid bone with tightly adherent dura. The medial optic canal roof (falciform ligament region) consists of thin bone and dura continuous with the tuberculum dura. This dural continuity allows small tumors to track directly into the intracanalicular optic nerve sheath, causing focal nerve compression inside a rigid bony corridor. Q. What is the epidemiology of tuberculum sellae meningiomas? They represent roughly 5% to 10% of all intracranial meningiomas and occur predominantly in middle-aged women. Because of their critical subchiasmatic location, patients generally present earlier and with a shorter duration of symptoms compared to those with meningiomas arising from the planum sphenoidale or olfactory groove. Q. Why do these tumors cause visual loss earlier than other skull-base meningiomas? Visual impairment occurs early because compression is directed from below at a point where the optic nerve is anchored by pial vessels and dural sleeves. In addition to direct mechanical mass effect, small tumors compromise the delicate vascular supply from the superior hypophyseal perforators, inducing focal ischemic dysfunction before significant structural displacement occurs. Intracanalicular extension further accelerates focal nerve ischemia. Q. What visual field defects and accompanying clinical features are typical? Visual Field Defects: The classic presentation is a junctional scotoma (ipsilateral central/cecocentral scotoma with contralateral superior temporal deficit) due to simultaneous compression of the prechiasmatic optic nerve and crossing inferonasal fibers from the opposite eye (Wilbrand's knee). Continued growth leads to bitemporal hemianopia or monocular blindness. Associated Symptoms: Dull frontal headache from dural traction, anosmia (if extended anteriorly onto the planum), and subtle hyperprolactinemia from stalk compression. Overt endocrine failure or cognitive changes are rare. Q. What are the characteristic findings on CT and MRI? CT: Shows a hyperdense, homogeneously enhancing extra-axial mass. Bone windows are critical to identify hyperostosis of the tuberculum or planum and to evaluate optic canal enlargement or hyperostotic narrowing. MRI: Demonstrates an extra-axial mass, isointense on T1 and T2, with uniform contrast enhancement and a dural tail along the tuberculum/planum. MRI highlights the classic upward and posterior arc of chiasm displacement, optic canal invasion, and encasement or displacement of the ICA and A1 branches. Q. How do you differentiate tuberculum sellae meningiomas from pituitary adenomas and planum sphenoidale meningiomas? Vs. Pituitary Adenoma: Meningiomas originate outside the sella, feature hyperostosis and a dural tail, compress the pituitary gland and stalk inferiorly (rather than expanding the sella from within), and frequently invade the optic canals, a feature extremely rare in adenomas. Vs. Planum Sphenoidale Meningioma: Tuberculum tumors originate more posteriorly and elevate the chiasm superiorly and backward. Planum tumors push the chiasm purely posteriorly without a significant upward lift, have a dural base centered further anteriorly, and show lower rates of optic canal invasion. Q. What is the differential diagnosis, histopathology, and molecular profile for these lesions? Differential Diagnosis: Pituitary adenoma, craniopharyngioma, planum sphenoidale meningioma, optic nerve sheath meningioma, hypothalamic glioma, parasellar chordoma, and germinoma. Histopathology & Molecular Features: Most are WHO Grade 1 meningothelial or transitional subtype. Anterior skull-base meningiomas frequently harbor AKT1 or SMO mutations. High-risk molecular markers, such as TERT promoter mutations or CDKN2A/B homozygous deletions, designate a tumor as WHO Grade 3 regardless of benign histological appearance. Q. What anatomical factors dictate the choice of surgical approach? Approach selection depends on the vector of optic nerve displacement, presence and extent of optic canal invasion, height of extension above the chiasm, lateral vascular encasement (ICA/A1), and tumor consistency. The goal is to maximize tumor exposure, enable early CSF release for brain relaxation, and afford direct visualization of the optic apparatus and superior hypophyseal perforators without brain retraction. Q. What are the indications, advantages, and limitations of the standard surgical routes for tuberculum sellae meningiomas? Pterional (Workhorse) Approach Key Indications: Standard choice for most tuberculum sellae meningiomas, particularly those with significant lateral extension into the sylvian fissure or prominent ipsilateral optic canal invasion. Primary Advantages: Provides early proximal vascular control of the internal carotid and ophthalmic arteries before tumor manipulation. Opening the basal cisterns allows rapid CSF drainage for early brain relaxation without heavy retraction. The lateral orientation provides a direct, natural angle to dissect along preserved arachnoid planes and an ideal vector for unroofing the ipsilateral optic canal. Main Limitations: Offers an oblique angle to the undersurface of the optic chiasm, making execution challenging when tumor extends into the contralateral optic canal or deeply behind the chiasm. Bifrontal Subfrontal Approach Key Indications: Massive midline tumors, cases with symmetric bilateral optic canal invasion, severe chiasmatic elevation, or extensive hyperostosis across the planum sphenoidale. Primary Advantages: Delivers an expansive, panoramic view of both optic nerves, both A1 segments, and both optic canals simultaneously. It provides superior access for extensive drilling of hyperostotic bone along the midline skull base. Main Limitations: Mandates bilateral frontal lobe retraction, carries a high risk of anosmia due to olfactory tract disruption, and frequently breaches the frontal sinus, elevating the risk of postoperative CSF leaks and infection. Unilateral Subfrontal / Eyebrow Keyhole Approach Key Indications: Small-to-medium midline tumors without significant vascular encasement or contralateral optic canal involvement. Primary Advantages: Provides a direct, front-on trajectory to the anterior skull base. The eyebrow mini-craniotomy variant minimizes soft tissue disruption, eliminates significant muscle division, avoids cosmetic deformity, and permits rapid surgical access. Main Limitations: Features a deep, narrow surgical corridor with rigid, restricted working angles. Visualizing behind critical neurovascular structures is difficult, and performing complex intracanicular optic canal unroofing through the keyhole is technically challenging. Extended Endoscopic Endonasal Approach (EEA) Key Indications: Selected small-to-medium, purely midline tumors that do not extend laterally beyond the optic nerves or internal carotid arteries and lack significant lateral optic canal invasion. Primary Advantages: Offers direct inferior access straight to the tumor base, allowing early devascularization from below without brain retraction. It provides a crisp, close-up visualization of the optic chiasm's undersurface and superior hypophyseal perforators. Main Limitations: Ineffective for lesions with significant lateral extension beyond the optic nerves or deep intracanicular involvement. It carries a substantially higher risk of postoperative CSF leak requiring complex skull-base reconstruction with a nasoseptal flap. Q. Step-by-step, how do you perform a pterional approach for a tuberculum sellae meningioma? Positioning & Craniotomy: Supine, head rotated 30 degrees contralateral and slightly extended. Standard frontotemporal craniotomy with extensive flattening of the sphenoid wing down to the superior orbital fissure. Cisternal Drainage & Exposure: Open the dura and sharply open the optico-carotid and chiasmatic cisterns to drain CSF, allowing the frontal lobe to fall back without mechanical retraction. Debulking & Dissection: Identify the ipsilateral ICA and optic nerve. Perform generous internal debulking using ultrasonic aspiration to collapse the capsule. Dissect strictly along preserved arachnoid planes to separate the tumor capsule from the optic nerve, chiasm, and A1 perforators. Optic Canal Unroofing: If canal invasion is present, unroof the medial canal roof with a diamond burr under continuous irrigation, remove eggshell bone with microcurettes, and incise the falciform ligament sharply to decompress the intracanicular optic nerve. Devascularization & Closure: Coagulate and detach the tumor base along the tuberculum dura, achieve complete tumor removal, verify hemostasis, and perform a watertight dural closure. Q. How does internal debulking protect the optic apparatus and superior hypophyseal perforators? Generous internal debulking is the critical step that prevents neurovascular injury. By gutting the rigid center of the mass, the outer capsule collapses inward. This creates slack in the surrounding arachnoid interface, allowing the surgeon to gently mobilize the capsule away from the optic nerves, chiasm, and superior hypophyseal perforators. Pulling on an intact, non-debulked tumor transmits destructive traction directly to these delicate structures. Q. How do you perform optic canal decompression, and why is it vital for visual recovery? Technique: Expose the medial canal roof, thin the bone with a diamond drill under continuous cold irrigation, and remove remaining bone flakes with microcurettes. Incise the falciform ligament sharply and open the perineural dura longitudinally to remove intracanicular tumor while safeguarding the ophthalmic artery. Rationale: The optic canal creates a rigid "bottleneck effect" where even minor tumor volume severely restricts nerve perfusion. Unroofing the canal, opening the falciform ligament, and debulking the dural sheath restores microvascular perfusion and physiologic pulsatility to the nerve. Q. How do you prevent injury to the superior hypophyseal perforators during dissection? Maintain a strict arachnoid-based technique, identifying perforators early and dissecting parallel to their natural course rather than pulling perpendicular to them. Avoid all bipolar coagulation in the chiasmatic cistern; use sharp micro-scissors to free tethering fibers. If a perforator is embedded in or inseparable from the tumor capsule, abandon radical resection at that site and leave a thin remnant of capsule to preserve visual function. Q. When is planned subtotal resection indicated over radical excision? Planned subtotal resection is indicated when the tumor capsule is densely adherent to the optic nerves, chiasm, or superior hypophyseal perforators, or when it firmly encases the ICA or A1 branches. Attempting to strip adherent tumor under these circumstances causes irreversible ischemic injury or stroke. Leaving a thin slice of capsule preserves vital neurological function, with the residual managed safely via observation or radiosurgery. Q. What are the primary causes of immediate versus delayed postoperative visual deterioration, and what intraoperative pitfalls contribute to them? Immediate Visual Deterioration: Caused by acute thrombosis of superior hypophyseal perforators, vasospasm, acute nerve edema, direct mechanical traction during capsule mobilization, or thermal injury from un-irrigated canal drilling. Delayed Visual Deterioration: Caused by progressive postoperative edema, delayed ischemic optic neuropathy, suprasellar hematoma formation, adhesive arachnoiditis, or persistent unaddressed canal compression. Intraoperative Pitfalls: Dissecting inside the tumor-nerve plane rather than within the arachnoid space, aggressive bipolar cautery near perforators, failing to open the falciform ligament, and pulling an intact tumor capsule without internal debulking. Q. What clinical and surgical factors predict postoperative visual outcome? Favorable Prognosis: Short duration of symptoms, mild preoperative visual deficit, preserved retinal nerve fiber layer thickness on OCT, soft tumor consistency, minimal canal invasion, and complete intraoperative preservation of superior hypophyseal perforators. Unfavorable Prognosis: Severe preoperative optic atrophy, long-standing visual loss (months to years), dense/circumferential optic canal invasion, firm/calcified tumor consistency, and intraoperative perforator or pial vessel compromise. Q. What other postoperative complications can occur, and what is the role of steroids? Complications: Postoperative CSF leak (highest with EEA), transient or permanent diabetes insipidus, hyperprolactinemia from stalk manipulation, ACA/ICA stroke, frontal lobe edema/contusion, and anosmia. Role of Steroids: Perioperative corticosteroids reduce peritumoral and optic nerve edema, stabilize the blood-brain barrier, and protect vulnerable, re-perfused optic nerve fibers during the acute recovery period. Q. When is adjuvant radiotherapy recommended, and what are the recurrence rates and follow-up protocols? Adjuvant Radiotherapy: Indicated for subtotal resection, recurrent disease, WHO Grade 2/3 tumors, or lesions harboring high-risk molecular features (TERT promoter mutation, CDKN2A/B deletion). Fractionated radiotherapy is preferred for residuals adjacent to the chiasm to minimize radiation-induced optic neuropathy, whereas stereotactic radiosurgery (SRS) is reserved for small remnants sitting >2–3 mm away from the optic apparatus. Recurrence & Prognosis: Recurrence rates are low (<5–10% at 5 years) following gross total resection (GTR) of WHO Grade 1 tumors, provided hyperostotic bone is drilled and involved dura is excised. Prognosis for WHO Grade 1 lesions is excellent, with visual recovery or stabilization achieved in over 80–90% of cases. Follow-up Protocol: Obtain a baseline contrast-enhanced MRI within 48 to 72 hours postoperatively. For WHO Grade 1 tumors with GTR, repeat MRI at 6 months, 1 year, and annually for at least 5 years, accompanied by formal ophthalmologic visual field testing. For subtotal resections or Grade 2/3 tumors, obtain serial MRI scans every 3 to 6 months.

Review cervical disc disease with concise neurosurgical notes covering cervical disc herniation, radiculopathy, myelopathy, imaging, indications, and surgical management. Cervical Disc Disease Cervical disc disease refers to degeneration or herniation of the intervertebral disc resulting in compression of the spinal cord or the exiting nerve root. Symptoms arise from mechanical compression, local inflammatory irritation by cytokines such as TNF- and IL-6, and ischemic compromise of the root. Herniation occurs posterolaterally where the annulus is thinnest and the posterior longitudinal ligament offers least support. Q. Which levels are most commonly affected? C5–C6 and C6–C7 are the commonest levels, followed by C4–C5. Accordingly, C6 and C7 roots are the most frequently involved. Q. What are the predisposing factors? Advancing age, repetitive neck movements, trauma, smoking, poor posture, and genetic predisposition contribute to disc degeneration and herniation. Q. How does cervical disc disease present? Typical presentation is neck pain radiating to one upper limb along a dermatomal pattern, often associated with paresthesia or numbness in the same distribution. The pain increases on neck extension or rotation. There may be segmental weakness and reflex loss corresponding to the affected root. Central or large herniations cause cervical myelopathy presenting as hand clumsiness, spasticity, gait disturbance, and sphincter urgency. Q. What are the characteristic root-wise findings? C4 root (C3–C4 disc, uncommon): Lower neck or trapezial pain with or without shoulder-tip paresthesia; no reliable reflex; mild hemidiaphragm weakness possible due to phrenic involvement; movement affected: neck elevation and inspiration (diaphragmatic component). C5 root (C4–C5 disc): Pain from neck to lateral upper arm; weakness of deltoid and biceps; diminished biceps reflex; sensory loss over lateral upper arm; movement affected: shoulder abduction and elbow flexion. C6 root (C5–C6 disc): Pain radiating to lateral forearm and thumb; weakness of wrist extensors and biceps; decreased brachioradialis reflex; sensory loss over lateral forearm, thumb, and index finger; movement affected: elbow flexion and wrist extension. C7 root (C6–C7 disc): Pain from neck and interscapular region to dorsal forearm and middle finger; weakness of triceps, wrist flexors, and finger extensors; decreased triceps reflex; sensory loss over middle finger; movement affected: elbow extension, wrist flexion, and finger extension. C8 root (C7–T1 disc): Pain in lower neck radiating to medial forearm and ring–little fingers; weakness of finger flexors and intrinsic hand muscles; no reliable deep tendon reflex; sensory loss over ulnar digits; movement affected: finger flexion and grip strength. T1 root (rare disc above T1): Medial arm pain and paresthesia; weakness of interossei causing impaired finger abduction; movement affected: finger abduction and adduction. Q. What are the typical signs on examination? Spurling’s test reproduces radicular pain when the head is extended and rotated toward the symptomatic side. Weakness, sensory loss, and reflex depression correspond to the affected root. The inverted radial reflex may appear in C5–C6 lesions. Myelopathy produces long-tract signs: hyperreflexia below the lesion, Hoffman or Babinski positivity, spasticity, gait imbalance, and loss of fine motor dexterity. Lhermitte’s phenomenon (Barber’s Sign) may be elicited by neck flexion. Hoffman’s becomes positive only when the corticospinal tract is compressed; it is absent in pure radiculopathy (long tract sign present in myelopathy). Q. How will you differentiate between root involvement and cord involvement? Root involvement causes lower motor neuron features at a single level: segmental weakness, flaccidity, atrophy, and reflex depression with preserved tone and reflexes below. Cord involvement produces upper motor neuron signs below the lesion: hyperreflexia, spasticity, Hoffman/Babinski positivity, and gait disturbance. The coexistence of both indicates combined spondylotic myeloradiculopathy. Q. What are the upper cervical presentations? C1 involvement causes deep suboccipital pain without sensory loss. C2 lesions produce occipital neuralgia radiating to the vertex. C3 lesions cause pain along the lateral neck and angle of the jaw. These levels have no limb weakness or reflex changes. If pyramidal signs are present, the compression lies at the cervicomedullary junction. Q. What imaging work-up will you perform and what do you expect to find? Plain radiographs (AP, lateral, and flexion–extension) are done to assess alignment and instability; obliques show foraminal osteophytes. MRI is the investigation of choice, it defines the level of disc herniation, canal diameter, and any cord compression or myelomalacia. Axial MRI best demonstrates posterior or paramedian disc displacement and root sleeve indentation. CT delineates osteophytes or ossified posterior longitudinal ligament. CT-myelography is reserved for patients in whom MRI is contraindicated. Q. What are the EMG and nerve-conduction findings? Needle EMG shows fibrillation potentials, positive sharp waves, and reduced recruitment in muscles supplied by the affected root. Sensory conduction studies are usually normal because the lesion is proximal to the dorsal root ganglion, while motor conduction may show mild delay if axonal loss exists. These studies help differentiate radiculopathy from peripheral entrapment neuropathies or plexopathies. Q. How will you manage cervical disc disease initially? Most acute radiculopathies recover with conservative therapy. This includes rest, short-term soft collar immobilization, NSAIDs, muscle relaxants, neuropathic pain agents, cervical traction, and physiotherapy. Epidural or selective nerve-root steroid injections may be used for persistent radicular pain. Q. When is surgery indicated? Surgery is considered for progressive neurological deficit, intractable radicular pain persisting beyond 6–12 weeks of adequate conservative treatment, or evidence of myelopathy or acute cord compression. Q. What are the surgical options? Anterior cervical discectomy and fusion remains the standard approach for ventral or central compressive pathology. Cervical disc arthroplasty is a motion-preserving alternative in young patients with one or two-level soft-disc disease and no instability or advanced spondylosis. Posterior keyhole foraminotomy or laminoforaminotomy is useful for lateral or foraminal soft-disc herniations. For multilevel canal stenosis or ossified posterior longitudinal ligament, posterior laminectomy or laminoplasty is performed depending on sagittal alignment. Q. What are the common complications of surgery, especially after ACDF? Complications include dysphagia, hoarseness from recurrent or superior laryngeal nerve injury, esophageal or tracheal injury, vertebral artery or spinal-cord injury, dural tear with CSF leak, graft or cage displacement, pseudoarthrosis, infection, airway obstruction due to hematoma, and late adjacent-segment degeneration. Q. How will you manage recurrence? Recurrence is evaluated with MRI to confirm the level and exclude pseudarthrosis or adjacent-segment disease. If pain is predominant without deficit, conservative measures and selective root blocks may be tried. For recurrent foraminal stenosis after anterior fusion, a posterior foraminotomy can decompress the root; if pseudarthrosis, graft collapse, or central compression is present, revision anterior fusion is indicated. Persistent or recurrent compression after posterior decompression is treated by anterior discectomy and fusion. Pseudarthrosis requires revision fusion, anterior or posterior, based on alignment and stability. Q. What is the prognosis after treatment? Radicular pain improves in most patients. Motor recovery depends on the severity and duration of preoperative weakness. In cases with established myelopathy or cord signal changes, residual spasticity or gait disturbance may persist despite adequate decompression.

Meet the team behind The Neurosurgical Case Room (TNCR), including its co-founder, strategic leadership and permanent reviewer working together to advance neurosurgical education. Co-Founder Dr. Etizaz Ahmed MBBS, MS Neurosurgery Co-Founder, The Neurosurgical Case Room Consultant Neurosurgeon, Indus Medical College Hospital, Pakistan Creative & Strategic Director Dr. Quratulain Jamal Narejo MBBS, MRCEM Primary Creative & Strategic Director, The Neurosurgical Case Room Indus Hospital & Health Network, Pakistan ACADEMIC ADVISOR & REVIEWER Dr. Hatice Büşra Cukaz MD Neurosurgery Academic Advisor & Reviewer, The Neurosurgical Case Room Consultant Neurosurgeon, Neurovascular/Endovascular Fellow Hyōgo College of Medicine Hospital, Japan

Explore arachnoid cysts with The Neurosurgical Case Room (TNCR), including classification, clinical presentation, imaging, natural history and principles of neurosurgical management. Arachnoid Cyst Q. What is an arachnoid cyst? An arachnoid cyst is a congenital, CSF-filled lesion arising from splitting or duplication of the arachnoid membrane. It is lined by arachnoid cells, contains fluid nearly identical to CSF, and displaces adjacent brain parenchyma, sometimes remodeling bone. It is not a neoplasm and is distinct from post-traumatic leptomeningeal cysts. Although arachnoid cysts may occur anywhere along the neuraxis, the most common sites are the middle cranial fossa, cerebellopontine angle, suprasellar region, and posterior fossa. Arachnoid cysts also occur in the spine. Q. What is the epidemiology of intracranial arachnoid cysts? Autopsy series report an incidence of approximately 1 per 500 persons. Arachnoid cysts comprise around 1% of all intracranial masses. They occur more commonly in males, with a male-to-female ratio of 4:1, and are more frequently found on the left side. Bilateral arachnoid cysts can occur, particularly in patients with metabolic disorders such as mucopolysaccharidoses. Q. What are the microscopic and histologic characteristics of arachnoid cysts? Two histological patterns exist: “Simple” arachnoid cysts show a delicate arachnoid lining with cells capable of minimal CSF secretion. Middle fossa cysts are almost always of this type. Complex cysts contain a mixed lining with potential mucin, ependyma, or other cell types, especially in unusual locations or syndromic patients. Arachnoid cysts are lined by epithelial membrane antigen–positive arachnoid cells and are negative for tumor markers such as CEA. Q. How are middle cranial fossa arachnoid cysts classified (Galassi)? The Galassi classification applies to Sylvian fissure/middle fossa cysts and contains three types: Type I: Small, anterior, biconvex cysts at the temporal tip, minimal mass effect, communicate freely with the subarachnoid space. Type II: Intermediate-sized cysts involving the proximal and intermediate Sylvian fissure; the insula is partly exposed; partial communication with the subarachnoid space is common. Type III: Large cysts occupying the entire middle cranial fossa, producing marked midline shift and bony expansion (elevation of sphenoid wing, outward displacement of squamous temporal bone). These have minimal communication with the subarachnoid space. Q. How are arachnoid cysts classified by location? Almost all arachnoid cysts occur in relation to an arachnoid cistern (intracisternal). The only exception is intrasellar cysts, which are extradural. Based on location, common sites include: • Sylvian fissure (most common, approximately half of all cysts) • CPA region • Supracollicular (quadrigeminal plate) • Vermian/posterior fossa • Sellar/suprasellar region • Interhemispheric fissure • Cerebral convexity • Clival • Spinal arachnoid space Q. How do arachnoid cysts form? They arise during embryogenesis from splitting or non-fusion of arachnoid membranes, creating a pocket that fills with CSF. They are therefore considered intra-arachnoid compartments. Fluid accumulates via CSF pulsation, passive diffusion, or a ball-valve effect. Secondary cysts may arise after infection, hemorrhage, trauma, or surgery; these have thickened walls or multiple septations. Q. What mechanisms allow arachnoid cysts to enlarge? Several mechanisms exist: A one-way valve leading to progressive CSF inflow Entrapment of CSF within an isolated arachnoid compartment Compression of adjacent arachnoid cisterns leading to unidirectional filling Intrinsic secretion from the cyst wall (rare) Impaired reabsorption or scarring of subarachnoid pathways Q. What is the importance of location in clinical presentation? Location determines which structures are compressed: Sylvian fissure: temporal lobe compression can lead to seizures and headaches Posterior fossa/vermis: hydrocephalus, ataxia Suprasellar: visual deficits, endocrine symptoms, precocious puberty, bobble-head doll syndrome, hydrocephalus Quadrigeminal plate: compression of posterior third ventricle can lead to obstructive hydrocephalus Convexity/interhemispheric: focal deficits, seizures Spinal: myelopathy, radicular pain Q. How do arachnoid cysts present clinically? Most are asymptomatic. Symptoms, when present, depend on location and cyst size. Typical presentations include: Intracranial hypertension: headache, nausea, vomiting, lethargy, irritability (especially in infants with large cysts). Seizures: particularly with middle fossa cysts due to temporal lobe irritation. Sudden deterioration: from intracystic or subdural hemorrhage (especially middle fossa cysts with tearing of bridging veins). Focal neurological deficit: due to space-occupying effect. Cosmetic skull deformity: outward bulging over the cyst. Incidental discovery: on imaging for unrelated issues. Suprasellar cysts have additional typical features: Hydrocephalus due to third ventricle/aqueduct compression Visual loss Endocrine disturbances including precocious puberty (occurs in up to 60%) “Bobble-head doll syndrome” (rare but classic), characterized by repetitive anteroposterior head movements Q. What CT features suggest an arachnoid cyst? CT shows a smooth, well-demarcated, non-calcified lesion with density nearly identical to CSF and no enhancement. Chronic cysts remodel adjacent bone in up to two-thirds of supratentorial and up to 80% of infratentorial cysts. The cyst may cause mass effect on adjacent structures, including lateral ventricle distortion or midline shift. Q. What MRI findings are characteristic of an arachnoid cyst? MRI is superior for evaluating cysts. The cyst follows CSF on all sequences: • Low T1, high T2 signal • Suppression on FLAIR • No diffusion restriction (epidermoids restrict) • No enhancement • Fine membranes may be visible on CISS/FIESTA sequences MRI can also show mass effect on the third/fourth ventricles, obstruction of foramina of Monro or aqueduct, and presence of septations. Q. What is the role of CT cisternography? CT cisternography involves the injection of intrathecal water-soluble contrast followed by high-resolution CT to evaluate contrast entry into the cyst. It is useful for: Determining communication between the cyst and subarachnoid space Differentiating true arachnoid cysts from loculated CSF spaces or diverticula Preoperative planning for fenestration (identifying best drainage pathways) Evaluation of intraventricular or posterior fossa cysts when MRI is inconclusive Confirming patency of a fenestration postoperatively Because some cysts only partially fill with contrast, interpretation must be correlated with MRI. Q. What are the treatment options for arachnoid cysts? Treatment depends on cyst location, size, symptoms, and communication with adjoining cisterns. Options include: Endoscopic fenestration into basal cisterns, ventricles, or both. Microsurgical fenestration via a craniotomy when endoscopic access is difficult or the cyst is multiloculated. Cystoperitoneal shunt as a definitive, low-recurrence option when other methods fail or are anatomically unsafe. Suboccipital or retrosigmoid fenestration for posterior fossa cysts. Spinal cyst fenestration or excision for intradural spinal lesions. Drainage alone (needle aspiration or burr hole) is avoided due to high recurrence. Ventricular drainage is contraindicated because it can worsen cyst enlargement. Q. What is the treatment of middle fossa arachnoid cysts? Middle fossa (Sylvian fissure) cysts are best treated by microsurgical fenestration into the basal cisterns, especially for large Type III lesions. Small, asymptomatic Type I lesions often require no treatment. Type II cysts may be treated with endoscopic fenestration when safe trajectories exist; however, microsurgical fenestration provides the most reliable and durable communication with the bulk cisterns. If fenestration fails or anatomy is unfavorable, cystoperitoneal shunting offers excellent long-term control and low recurrence. Q. What is the best treatment for suprasellar arachnoid cysts? The best and most durable treatment for suprasellar arachnoid cysts is endoscopic ventriculocystocisternostomy (VCC). This creates a wide communication between: The cyst The third ventricle The interpeduncular and prepontine cisterns VCC allows continuous CSF circulation and has the lowest recurrence rate among all treatments. Endoscopic ventriculocystostomy (VC) alone is less durable because it does not reestablish cisternal flow. Microsurgical subfrontal approaches are reserved for cases where endoscopic access is not possible. Q. What is the best treatment for posterior fossa arachnoid cysts? Posterior fossa cysts compressing brainstem or cerebellum are treated via a midline suboccipital or retrosigmoid fenestration into the cisterna magna or prepontine cistern. Endoscopic treatment is rarely feasible in posterior fossa due to limited endoscopic corridors. Q. What is the best treatment for intraventricular arachnoid cysts? These lesions are treated by neuroendoscopic fenestration into the ventricular system and adjacent cisterns. CT cisternography can help determine communication before surgery. Shunting is reserved for multiloculated or recurrent cysts. Q. How will you surgically treat an arachnoid cyst? (Microsurgical Fenestration) I will begin by reviewing high-resolution MRI, focusing on the cyst’s relationship to arteries, veins, cranial nerves, ventricles, and cisterns. Based on its location, I will select an optimal operative approach. For middle fossa cysts, I will commonly use a pterional craniotomy. For suprasellar cysts, I will plan a burr hole approach for neuroendoscopic ventriculocystocisternostomy. For posterior fossa lesions, I will choose a midline suboccipital or retrosigmoid exposure. After positioning and preparing the patient, I will open the dura and gently expose the cyst wall under the microscope or endoscope. I will cautiously dissect arachnoid membranes away from the cyst, protecting cortical vessels and perforators. Once I identify the cisternal or ventricular boundary, I will create a wide fenestration in the cyst wall using microscissors or bipolar forceps, ensuring a robust opening that cannot close spontaneously. If the cyst has internal septations, I will open each one to create a single cavity. For suprasellar cysts, I will identify the floor of the third ventricle, the lamina terminalis, and the interpeduncular cistern, and I will perform a ventriculocystocisternostomy to establish strong dual communication with both ventricle and cistern. I will confirm that CSF flow passes freely through the fenestrations and that no neural or vascular structures are entrapped. If the fenestration is not feasible or if the cyst is multiloculated and deep, I will place a cystoperitoneal shunt using a low-pressure valve to maintain gradual decompression. I will then irrigate, achieve hemostasis, and close all layers meticulously. Postoperatively, I will monitor for neurological improvement, signs of CSF leak, and subdural collections. Follow-up MRI will confirm cyst decompression and patency of fenestrations. Q. What are the perioperative complications of arachnoid cyst surgery? These include: Injury to adjacent cortex, cranial nerves, or perforator vessels Hemorrhage into the cyst or subdural space CSF leak Failure to adequately fenestrate cyst walls Injury to optic apparatus in suprasellar cases Brainstem injury in posterior fossa approaches Q. What are the postoperative complications? Postoperative complications include: Subdural hygroma (most common) due to rapid decompression of a large cyst Subdural hematoma Recurrence due to closure of fenestration Persistent hydrocephalus Shunt dependency if a shunt was placed Seizures in patients with temporal lobe involvement Visual or endocrine deterioration in suprasellar cysts if decompression is inadequate Q. How will you counsel the patient or parents before surgery? I will explain that arachnoid cysts are benign lesions that often remain stable, but surgery is indicated when symptoms or progressive enlargement occur. I will emphasize that the goal is to restore normal CSF circulation by fenestrating the cyst into cisterns or ventricles. I will discuss risks such as subdural collections, recurrence, cranial nerve deficits (depending on location), and the possibility of needing a shunt. For suprasellar cysts, I will clarify that endoscopic ventriculocystocisternostomy offers the best long-term results and carries a low recurrence rate. I will address seizure prognosis in temporal cyst cases and reassure parents that many children improve after decompression. Q. What is the prognosis after surgery for arachnoid cysts? Prognosis is excellent. Most symptomatic patients show significant improvement in headaches, hydrocephalus, visual symptoms, or developmental delay. Suprasellar cyst symptoms, especially visual decline and bobble-head doll syndrome, often improve dramatically with timely VCC. Recurrence is uncommon when wide fenestrations are created. Shunted cysts function well but require lifelong surveillance for shunt malfunction. Seizure control depends on underlying cortical pathology; some patients continue to require antiepileptic therapy despite cyst decompression. Reference: Greenberg's Handbook of Neurosurgery, 10th Edition